| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 12 |
| 1 | UPADACITINIB | 11 |
| 2 | ADALIMUMAB | 10 |
| 3 | INFLIXIMAB | 10 |
| 4 | RITUXIMAB | 10 |
| 5 | ABATACEPT | 9 |
| 6 | ADALIMUMAB-AATY | 9 |
| 7 | ADALIMUMAB-ADAZ | 9 |
| 8 | ADALIMUMAB-FKJP | 9 |
| 9 | ETANERCEPT | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 7 | 0.0023 |
| 1 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 2 | SARILUMAB | 9 | 0.0003 |
| 3 | PREDNISOLONE ACETATE | 3 | 0.0003 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 5 | ADALIMUMAB-FKJP | 9 | 0.0002 |
| 6 | ADALIMUMAB-AATY | 9 | 0.0002 |
| 7 | ADALIMUMAB-ADAZ | 9 | 0.0002 |
| 8 | UPADACITINIB | 11 | 0.0001 |
| 9 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 12 | 0.0001 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 9 | 0.0001 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 9 | 0.0001 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 10 | 0.0000 |
| 5 | Proteasome Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 6 | 0.0000 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 8 | 0.0000 |
| 9 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |